DK644388A - Farmaceutiske praeparater indeholdende 3-hydroxy-smoeresyrederivater - Google Patents

Farmaceutiske praeparater indeholdende 3-hydroxy-smoeresyrederivater

Info

Publication number
DK644388A
DK644388A DK644388A DK644388A DK644388A DK 644388 A DK644388 A DK 644388A DK 644388 A DK644388 A DK 644388A DK 644388 A DK644388 A DK 644388A DK 644388 A DK644388 A DK 644388A
Authority
DK
Denmark
Prior art keywords
hydroxy
acid derivatives
pharmaceutical preparations
preparations containing
lubric
Prior art date
Application number
DK644388A
Other languages
English (en)
Other versions
DK644388D0 (da
DK168269B1 (da
Inventor
William Nichels
Oultremont Philippe D
Original Assignee
Solvay
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay filed Critical Solvay
Publication of DK644388D0 publication Critical patent/DK644388D0/da
Publication of DK644388A publication Critical patent/DK644388A/da
Application granted granted Critical
Publication of DK168269B1 publication Critical patent/DK168269B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • External Artificial Organs (AREA)
DK644388A 1987-11-19 1988-11-18 Farmaceutiske præparater indeholdende 3-hydroxysmøresyrederivater og dialyseopløsning, der er egnet til peritoneal dialyse DK168269B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
BE8701314A BE1001209A3 (fr) 1987-11-19 1987-11-19 Compositions pharmaceutiques contenant un derive de l'acide 3-hydroxybutanoique choisi parmi les oligomeres de cet acide et les esters de cet acide ou de ces oligomeres avec du 1,3-butanediol.
BE8701314 1987-11-19

Publications (3)

Publication Number Publication Date
DK644388D0 DK644388D0 (da) 1988-11-18
DK644388A true DK644388A (da) 1989-07-03
DK168269B1 DK168269B1 (da) 1994-03-07

Family

ID=3882973

Family Applications (1)

Application Number Title Priority Date Filing Date
DK644388A DK168269B1 (da) 1987-11-19 1988-11-18 Farmaceutiske præparater indeholdende 3-hydroxysmøresyrederivater og dialyseopløsning, der er egnet til peritoneal dialyse

Country Status (10)

Country Link
US (1) US5112865A (da)
EP (1) EP0316993B1 (da)
JP (1) JPH01160917A (da)
AT (1) ATE65397T1 (da)
BE (1) BE1001209A3 (da)
CA (1) CA1330307C (da)
DE (1) DE3863904D1 (da)
DK (1) DK168269B1 (da)
ES (1) ES2037818T3 (da)
GR (1) GR3002605T3 (da)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5126373A (en) * 1987-11-19 1992-06-30 Henri Brunengraber Composition for parenteral and oral nutrition
CN1315473C (zh) * 1997-03-17 2007-05-16 英国技术集团国际有限公司 治疗组合物
US20090253781A1 (en) * 2002-05-24 2009-10-08 Btg International Limited Therapeutic compositions
US6323237B1 (en) * 1997-03-17 2001-11-27 Btg International Limited Therapeutic compositions
US6164451A (en) * 1998-03-16 2000-12-26 Trish Mcevoy, Ltd. Cosmetics case
DE19830310A1 (de) * 1998-07-07 2000-01-13 Riedel De Haen Gmbh Verfahren zur Abreicherung des Bromidgehaltes aus einer wäßrigen Bromid enthaltenden Lösung unter Verwendung von Wasserstoffperoxid
CA2338090C (en) 1998-07-22 2009-07-14 Metabolix, Inc. Nutritional and therapeutic compositions of 3-hydroxyacids for increasing blood ketone bodies
US20020077269A1 (en) * 2000-10-27 2002-06-20 Whitehouse Robert S. Alkanoic acid ester monomer compositions and methods of making same
US6897338B2 (en) * 2001-12-18 2005-05-24 Metabolix, Inc. Methods of making intermediates from polyhydroxyalkanoates
DK1648952T3 (da) * 2003-06-03 2018-05-28 The Us Gov As Represented By The Department Of Health And Human Services Kosttilskud og terapeutiske sammensætninger omfattende (R)-3-hydroxybutyrat-derivater
GB0410266D0 (en) * 2004-05-07 2004-06-09 Ketocytonyx Inc Treatment of apoptosis
WO2009089144A1 (en) 2008-01-04 2009-07-16 Isis Innovation Limited Ketone bodies and ketone body esters as blood lipid lowering agents
US8642654B2 (en) * 2009-04-16 2014-02-04 Isis Innovation Limited Hydroxybutyrate ester and medical use thereof
ES2655367T3 (es) * 2008-08-21 2018-02-19 Oxford University Innovation Limited Bebida que comprende éster de hidroxibutirato y uso médico de la misma
CN102781901B (zh) 2010-02-11 2016-08-03 梅塔玻利克斯公司 用于从经遗传修饰的聚羟基链烷酸酯生物质制备单体组分的方法
GB201002983D0 (en) 2010-02-22 2010-04-07 Tdeltas Ltd Nutritinal composition
WO2014071389A1 (en) 2012-11-05 2014-05-08 Veech Richard L Ketone bodies to protect tissues from damage by ionizing radiation
GB201304467D0 (en) 2013-03-12 2013-04-24 Tdeltas Ltd Compound for use in protecting skin
GB2515603B (en) 2013-03-14 2015-10-14 Isis Innovation Process for producing (R)-3-Hydroxybutyl (R)-3-Hydroxybutyrate
RU2761829C2 (ru) 2016-06-07 2021-12-13 Зе Дж. Дэвид Глэдстоун Инститьютс Образуемые среднецепочечными жирными кислотами сложные эфиры бета-гидроксибутирата и бутандиола и композиции и способы на их основе
US11760963B2 (en) 2017-08-23 2023-09-19 KetoneAid Inc. Ketogenic beer and alcoholic beverage mixture containing non-racemic ethyl 3-hydroxybutyrate and/or 1,3 butanediol
US20180057846A1 (en) 2016-08-30 2018-03-01 KetoneAid Inc. Partially buffered free acid and/or ketone blend for rapid onset ketosis and metabolic therapy
BR112020001285A2 (pt) * 2017-07-21 2020-07-28 Buck Institute For Research On Aging s-enantiômeros de beta-hidroxibutirato e butanodiol e métodos para sua utilização
US12037317B2 (en) 2018-01-25 2024-07-16 Buck Institute For Research On Aging Synthesis of 3-hydroxybutyryl 3-hydroxybutyrate and related compounds
WO2021195477A1 (en) 2020-03-27 2021-09-30 Ketoneaid, Inc. Ketone ester as a therapeutic treatment of covid-19, long covid, and related viral infections

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2500312C2 (de) * 1975-01-07 1984-01-19 Basf Ag, 6700 Ludwigshafen Verfahren zur Herstellung von Butandiol-(1,3)-3-mono-(3'-hydroxybutyraten)sowie einige dieser Butandiol-(1,3)-3-mono-(3'-hydroxybutyrate)
DE2500310C2 (de) * 1975-01-07 1984-01-19 Basf Ag, 6700 Ludwigshafen Verfahren zur Herstellung von Butandiol-(1,3)-1-mono-(3'-hydroxybutyraten)sowie einige dieser Butandiol-(1,3)-1-mono-(3'-hydroxybutyrate)
FR2486072A1 (fr) 1980-07-03 1982-01-08 Solvay Procede pour la fabrication de l'acide b-hydroxybutyrique et de ses oligocondensats
US4574085A (en) * 1981-05-15 1986-03-04 Baxter Travenol Laboratories, Inc. Method for using dialysis solution containing glycerol
FR2521857B1 (fr) * 1982-02-23 1985-10-31 Solvay Compositions pharmaceutiques contenant de l'acide 3-hydroxybutanoique ou un sel derive de cet acide et sels derives de l'acide 3-hydroxybutanoique et d'une base organique azotee
JPS63502274A (ja) * 1985-12-18 1988-09-01 ビ−チ，リチヤ−ド　エル Ｌ↓−乳酸および／またはピルビン酸アニオンを用いた流体式治療法

Also Published As

Publication number Publication date
US5112865A (en) 1992-05-12
GR3002605T3 (en) 1993-01-25
EP0316993A1 (fr) 1989-05-24
DE3863904D1 (de) 1991-08-29
DK644388D0 (da) 1988-11-18
ATE65397T1 (de) 1991-08-15
ES2037818T3 (es) 1993-07-01
EP0316993B1 (fr) 1991-07-24
BE1001209A3 (fr) 1989-08-22
DK168269B1 (da) 1994-03-07
CA1330307C (fr) 1994-06-21
JPH01160917A (ja) 1989-06-23

Similar Documents

Publication Publication Date Title
DK644388D0 (da) Farmaceutiske praeparater indeholdende 3-hydroxy-smoeresyrederivater
NO882732D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive aminosyrederivater.
NO890921D0 (no) Fremgangsmaate for fremstilling av aminosyrederivater.
NO862734D0 (no) Fremgangsmaate for fremstilling av hyaluronsyreestere.
NO179359C (no) Fremgangsmåte for fremstilling av farmasöytisk preparat inneholdende somatostatinanaloger.
DE3880667D1 (de) Ampulle zur gesteuerten verabreichung eines heilmittels.
DE3866737D1 (de) Bisphosphonsaeure-derivate und sie enthaltende arzneimittel.
FI891245L (fi) Starka soetningsmedel.
NO165071C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 7-(3-amino-1-pyrrolidinyl)-8-klor-1-cyklopropyl-6- fluor-1,4,-dihydro-4-okso-3-kinolin-karboksylsyre.
DK642588D0 (da) Indanderivater, fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende samme
ES2018667B3 (es) Derivados del acido 4-qionolon-3-carboxilico, procedimiento para su obtencion y preparados farmaceuticos que los contienen.
FI883638A7 (fi) Menetelmä haavan paranemista edistävien lääkeainevalmisteiden valmistamiseksi.
FI882165A7 (fi) Menetelmä 4-amino-androsteenidioni-johdannaisten valmistamiseksi.
DK612788A (da) Alkoxyderivater af ginkolider, fremgangsmaade til fremstilling heraf og farmaceutiske praeparater indeholdende saadanne forbindelser
DK561589A (da) Flydende oralt farmaceutisk praeparat
IT8621230A0 (it) Policarbonati ramificati contenenti acidi alifatici policarbossilici o loro derivati e procedimento per la loro preparazione.
DK635988D0 (da) 1,3-butandiolacetoacetat-derivater og anvendelse af 1,3-butandiolacetoacetat-forbindelser til fremstilling af farmaceutiske praeparater
OA09794A (fr) Dérivés de pyridone amino acide azetidinyl substitués, leur préparation et leur application en tant que médicaments.
IT1228437B (it) "derivati di 2,3,4,5,6,7 esaidro 2,7-metano-1,5 benzossazonina (rispettivamente 1,4 benzossazonina), procedimento per la loro preparazione e prodotti medicinali che contengono questi composti.
NO165542C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-aryl-2,4-dialkyl-3h-1,2,4-triazol-3-thioner.
ATE137487T1 (de) Komplexe, enthaltend s(+)-phenyl-alkansäuren und alpha-hydroxy-alkansäuren
DK229089A (da) Peptid-laegemiddelpraeparater indeholdende alfa-aminoborsyrederivater til indgift via slimhinden
FI881032A7 (fi) Menetelmä N-asetyyli-3 -fluorineuramiinihappojohdannaisten valmistamiseksi.
DK417889A (da) Anvendelse af 2-azabicyklo(2.2.2.)-carboxylsyrederivater til fremstilling af medicinske produkter til behandling af vaskulaere sygdomme
NO863005D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive 1,4,5,6,7,8-heksahydro-2-alkyl-4-aryl-5-okso-1,7-naftyridin-3-karboksylsyreesterderivater.

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed